Bernstein estimates the potential market for drugs that stop protein ‘strangling’ of the heart (ATTR-CM) to be worth $20 billion ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE